Spatial transcriptomics identifies tumor-intrinsic and stromal programs associated with immune exclusion in NSCLC
It is shown that spatial CD8+ T-cell exclusion is associated with lower objective response rates and shorter progression-free survival in ICB-treated NSCLC patients, and further evaluation of spatial immune contexture as a complementary biomarker in ICB-treated patients is supported.